A Study of ASP1570 Taken by Itself, or ASP1570 Taken Together With Either Pembrolizumab, Standard Therapies, or Both, in Adults With Solid Tumors

NCT05083481 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

226

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumors

Interventions

DRUG: ASP1570
DRUG: pembrolizumab
DRUG: Trifluridine + Tipiracil
DRUG: Bevacizumab
DRUG: Docetaxel
DRUG: Oxaliplatin
DRUG: Leucovorin
DRUG: 5-Fluorouracil
DRUG: Irinotecan
DRUG: Pemetrexed
DRUG: Carboplatin

Sponsor

Astellas Pharma Global Development, Inc.

Collaborators

[object Object]